Literature DB >> 30417350

MiRNAs and inflammatory bowel disease: An interesting new story.

Soheila Moein1,2, Mostafa Vaghari-Tabari2,3, Durdi Qujeq4,5, Maryam Majidinia6, Seyed Mohammad Nabavi7, Bahman Yousefi8,9.   

Abstract

Inflammatory bowel disease (IBD), as a chronic and recurrent inflammatory disorder, is caused by a dysregulated and aberrant immune response to exposed environmental factors in genetically susceptible individuals. Despite huge efforts in determining the molecular pathogenesis of IBD, an increasing worldwide incidence of IBD has been reported. MicroRNAs (miRNAs) are a set of noncoding RNA molecules that are about 22 nucleotides long, and these molecules are involved in the regulation of the gene expression. By clarifying the important role of miRNAs in a number of diseases, their role was also considered in IBD; numerous studies have been performed on this topic. In this review, we attempt to summarize a number of studies and discuss some of the recent developments in the roles of miRNAs in the pathophysiology, diagnosis, and treatment of IBD.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  apoptosis; autophagy; inflammation; inflammatory bowel disease; microRNA

Mesh:

Substances:

Year:  2018        PMID: 30417350     DOI: 10.1002/jcp.27173

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

1.  Strictosamide alleviates the inflammation in an acute ulcerative colitis (UC) model.

Authors:  Qinghui Jia; Haihua Zhang; Yongmei Su; Xin Liu; Jiangsong Bai; Wuying Lang; Qiumei Shi; Minshan Feng
Journal:  J Physiol Biochem       Date:  2021-02-17       Impact factor: 4.158

2.  The intestinal microbiota influences the microenvironment of metastatic colon cancer by targeting miRNAs.

Authors:  Shihai Zhou; Canhua Zhu; Shaoqin Jin; Chunhui Cui; Linghui Xiao; Zhi Yang; Xi Wang; Jinlong Yu
Journal:  FEMS Microbiol Lett       Date:  2022-06-14       Impact factor: 2.820

Review 3.  CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer.

Authors:  Mostafa Vaghari-Tabari; Parisa Hassanpour; Fatemeh Sadeghsoltani; Faezeh Malakoti; Forough Alemi; Durdi Qujeq; Zatollah Asemi; Bahman Yousefi
Journal:  Cell Mol Biol Lett       Date:  2022-06-17       Impact factor: 8.702

Review 4.  Zinc and Selenium in Inflammatory Bowel Disease: Trace Elements with Key Roles?

Authors:  Mostafa Vaghari-Tabari; Davoud Jafari-Gharabaghlou; Fatemeh Sadeghsoltani; Parisa Hassanpour; Durdi Qujeq; Nadereh Rashtchizadeh; Amir Ghorbanihaghjo
Journal:  Biol Trace Elem Res       Date:  2020-10-23       Impact factor: 3.738

5.  Autologous Exosome Transfer: A New Personalised Treatment Concept to Prevent Colitis in a Murine Model.

Authors:  Chunhua Yang; Mingzhen Zhang; Junsik Sung; Lixin Wang; Yunjin Jung; Didier Merlin
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

Review 6.  From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?

Authors:  Mostafa Vaghari-Tabari; Niloufar Targhazeh; Soheila Moein; Durdi Qujeq; Forough Alemi; Maryam Majidina; Simin Younesi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

Review 7.  Exosomal miRNAs in osteoarthritis.

Authors:  Aynaz Mihanfar; Seyed Kazem Shakouri; Mohammad Hassan Khadem-Ansari; Amir Fattahi; Zeinab Latifi; Hamid Reza Nejabati; Mohammad Nouri
Journal:  Mol Biol Rep       Date:  2020-04-10       Impact factor: 2.742

Review 8.  From Genetics to Epigenetics, Roles of Epigenetics in Inflammatory Bowel Disease.

Authors:  Zhen Zeng; Arjudeb Mukherjee; Hu Zhang
Journal:  Front Genet       Date:  2019-10-31       Impact factor: 4.599

9.  IFN-γ promoted exosomes from mesenchymal stem cells to attenuate colitis via miR-125a and miR-125b.

Authors:  Ruili Yang; Huaming Huang; Shengjie Cui; Yikun Zhou; Ting Zhang; Yanheng Zhou
Journal:  Cell Death Dis       Date:  2020-07-30       Impact factor: 8.469

Review 10.  MicroRNA Biomarkers in IBD-Differential Diagnosis and Prediction of Colitis-Associated Cancer.

Authors:  Jaslin P James; Lene Buhl Riis; Mikkel Malham; Estrid Høgdall; Ebbe Langholz; Boye S Nielsen
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.